3183-64-0Relevant articles and documents
MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
-
Page/Page column 190, (2008/06/13)
The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
Transition metal compound, olefin polymerization catalyst component comprising the transition metal compound, olefin polymerization catalyst comprising the olefin polymerization catalyst component, and process for olefin polymerization
-
, (2008/06/13)
Disclosed is a novel transition metal compound represented by the following formula: STR1 wherein M is a transition metal, X is halogen or the like, R1 is a hydrocarbon group or the like, R2 is an aryl group substituted with a halogenated hydrocarbon group, and Y is a divalent silicon-containing group or the like. Also disclosed are an olefin polymerization catalyst component comprising the transition metal compound, an olefin polymerization catalyst comprising the olefin polymerization catalyst component, and a process for olefin polymerization using the olefin polymerization catalyst. An olefin polymerization catalyst component having high polymerization activity can be formed from the transition metal compound. By the use of the olefin polymerization catalyst or the process for olefin polymerization, polyolefins having a high melting point and a high molecular weight can be prepared with high polymerization activity.
Antiperspirants
-
, (2008/06/13)
Compounds represented by the formula wherein m and n each are 1 or 2 and the sum of m and n is 3; R1 is alkyl; R2 is substituted and unsubstituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, alkanoyl, alkenoyl or aroyl; wherein the substituents on R2 when R2 is alkyl, alkenyl, alkanoyl and alkenoyl are one or more of cycloalkyl, cycloalkenyl, alkyl substituted cycloalkenyl, or aryl, alkoxy, cycloalkoxy, cycloalkenyloxy, aryloxy or alkyl and/or alkoxy substituted aryl, alkoxy, cycloalkoxy, cycloalkenyloxy or aryloxy; and wherein the substituents on R2 when R2 is cycloalkyl, cycloalkenyl, aryl and aroyl are one or more of alkyl, alkoxy or aryl; and when R2 is phenyl two adjacent alkyl and/or alkoxy substituents on the phenyl can be joined to form a 5 or 6-membered saturated ring; when m is 2 and n is 1, R2 can be wherein R1 has the significance above and each R1 can be the same or different, R3 is a straight chain alkylene of 2 to 4 carbons and p is 0, 1 or 2; when m is 1 and n is 2, R2 has the significance above and each R2 can be the same or different or when one R2 is alkyl the other R2 can be STR1 WHEREIN R1 has the significance above and R4 is alkyl; are disclosed as having activity as antiperspirants. Antiperspirant/deodorant compositions containing one or more of the compounds as active ingredients and methods for preparing the compounds are also disclosed.